🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our senior scientist Lucy Bock presented our work on bacterial impedance cytometry in Amsterdam yesterday AMR Insights

Our first foray into #antimicrobial peptide formulation with Karin Kogermann AD3, UKHSA: Fibrous matrices facilitate pleurocidin killing of wound associated ba... sciencedirect.com/science/articl…

Welcome AMRDx Scientists & Developers worldwide to B2B2B: Include your AMR Diagnostics (ID & AST) Technology in AMR Insights Technology Directory: Objective 1 of JPIAMR B2B2B network. See slide show: amr-insights.eu/b2b2b/ #AMR #antimicrobialresistance #AMRDx #diagnostics

Here, we use cell-free synthetic biology to study antimicrobials and resistance. nature.com/articles/s4425… Thank you to all the authors and the reviewers. Kameshwari Chengan AD3, UKHSA Dr. Anastasios Tsaousis Josebengoechea

Nice work from Seong Heun Kim Daniele Castagnolo Charlie Hind AD3, UKHSA Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to Antibiotics | ACS Medicinal Chemistry Letters pubs.acs.org/doi/10.1021/ac…

Instead of looking for new #antibacterials, why not to sensitize Gram-negative #bacteria to common #antibiotics? Check out our last work on the discovery of lipoguanidines ACS Med Chem Lett. UCL Chemistry School of Cancer & Pharmaceutical Sciences AD3, UKHSA. #sustainability pubs.acs.org/doi/10.1021/ac…

🔵 News: We are excited to announce the UK Health Security Agency as the first PACE collaboration to help tackle deadly #AMR. 🔗 eu1.hubs.ly/H07HQRT0 @InnovateUK | LifeArc | Medicines Discovery Catapult

Very exciting to be involved in this! PACE (Pathways to Antimicrobial Clinical Efficacy) has today announced a partnership with the UK Health Security Agency (UKHSA) to support innovators developing new antimicrobials politicshome.com/members/articl…

JOB!! Based at KCL, in collaboration with us, this research-focused role will be to support a Medical Research Council (MRC) Gap Fund project for designing novel multifunctional nanomedicines using ferritin nanocage. Closing date April 2nd. kcl.ac.uk/jobs/086548-re…

Lucy will be presenting "#BacterialImpedanceCytometry - Gaining insights into bacterial responses to antimicrobials" at this year's #ECCMID2024 on Tuesday 30 April 8.30am Hall B. Find out what the technology could tell you about your bacteria's responses to antimicrobials!

'Dr Ron Daniels sees the impact of antimicrobial resistance (AMR), especially on people who develop sepsis, which claims around 48,000 lives in the UK each year. That’s more than breast cancer, bowel cancer and prostate cancer combined.' raconteur.net/healthcare/com…

Lucy is looking forward to presenting our #BacterialImpedanceCytometry project at the International Society of Antimicrobial Chemotherapy #ISAC webinar

I am very lucky to be presenting my poster at Microbiology Society 🦠🔬! My poster is B141! Please come and have a chat to learn all about - “Bacterial impedance cytometry (BIC): Gaining insights into bacterial stress responses in individual bacteria exposed to antibiotics.”

Congratulations to the newly anointed Dr Mahnoor Hassan! Barry and I are very proud supervisors. Thanks to Ilias and David for examining

Barry and Mahnoor have been doing really creative work, finding new ways to identify antifungals. Thanks to Charlie Hind for enabling another fantastic collaboration between School of Cancer & Pharmaceutical Sciences and AD3, UKHSA

New action plan to tackle antimicrobial resistance (AMR) commits the UK to: 🔵 reduce use of antimicrobials 🔵 strengthen surveillance of drug resistant infections before they emerge 🔵 incentivise industry to develop the next generation of treatments gov.uk/government/new…

#sepsis #diagnosis #criticalillness development of diagnostic tests for early diagnosis of sepsis and other severe inflammation conditions are keys to success in saving lives.. see what we are doing here.. lnkd.in/e4wGZuwE

New pre-print from the group - C7-substituted Quinolines as Potent Inhibitors of AdeG Efflux Pumps in Acinetobacter baumannii. The work was led by Yiling (Ivy) Zhu in collaboration with AD3, UKHSA biorxiv.org/content/10.110…

I'll be giving a joint webinar for The Scientist, on using cell-free synthetic biology for #AMR. Oct 10th, 2024 9:30-11:00 AM ET (2:00-4:00 PM BST) Research from QM_SBBS QMUL Sci & Eng News AD3, UKHSA Biotechnology and Biological Sciences Research The Royal Society Biochemical Society the-scientist.com/spying-on-the-…

New pre-print from the group in collaboration with AD3, UKHSA. We report new generation modified azole antifungals against multidrug-resistant Candida auris | ChemRxiv - go.shr.lc/4edhRxc